Navigation Links
Prominent Health Care Executive Joins Stemedica Board Of Directors
Date:12/1/2009

Anthony M. Marlon, MD was elected to the Stemedica Cell Technologies, Inc. (“Stemedica”) Board of Directors at the Company’s November 20th Board Meeting.

(PRWEB) December 1, 2009 -- Anthony M. Marlon, MD was elected to the Stemedica Cell Technologies, Inc. (“Stemedica”) Board of Directors at the Company’s November 20th Board Meeting. Roger J. Howe, PhD, Executive Chairman for Stemedica made the announcement, “We are fortunate to have someone of Dr. Marlon’s experience, expertise and stature joining our Board. He brings first hand experience to our Board as a physician and as a prominent business leader within the health care industry for the past thirty seven years.”

Dr. Marlon was Chairman of the Board and Chief Executive Officer of Sierra Health Services, Inc. (“Sierra”), a publicly traded healthcare company headquartered in Las Vegas, Nevada. Founded in 1984, Sierra was a diversified managed healthcare company that provided and/or administered benefit plans for employers, government programs and individuals predominately in Nevada. Sierra was comprised of a family of health-related subsidiaries including Health Plan of Nevada, Nevada’s largest health maintenance organization (HMO). In February of 2008, Sierra and its subsidiaries became part of United Healthcare where he was asked to serve as a consultant through February of this year.

Dr. Marlon was a member of the Board of Directors of America’s Health Insurance Plans (AHIP), and remains a Board Member of the Nevada Development Authority and the University of Nevada Las Vegas (UNLV) Foundation. In 1992, Dr. Marlon was appointed to the Federal Task Force on Long Term Health Care Policies. For thirteen years, Dr. Marlon’s leadership skills were called on as a member of the Government Affairs Committee of the Las Vegas Chamber of Commerce. “Dr. Marlon provides Stemedica with an expertise in health care development, regulatory approval processes and insurance reimbursement models that is unparalleled,” said Maynard A. Howe, PhD, Stemedica’s Vice Chairman & CEO. “Anthony will be invaluable to both our Board and our Senior Management as we help to pioneer regulatory and reimbursement models for countries around the world.”

Dr. Marlon was born in New York City. He attended the College of the Holy Cross in Worcester, Massachusetts where he received a Bachelor of Science degree in 1963. He earned his Doctor of Medicine degree at State University of New York in 1967. At Stanford University Hospital in Palo Alto, California, he served as a medical intern from 1967-1968; as an internal medicine resident from 1968-1970; and as a Cardiology Fellow from 1970-1972. Dr. Marlon moved to Las Vegas in July of 1972 and was affiliated with University Medical Center as Chief of the Division of Cardiology. Dr. Marlon has been a speaker for various medical institutions, universities, and health groups and has written numerous cardiology related articles for medical publications.

About Stemedica Cell Technologies
Stemedica Cell Technologies Inc. (www.stemedica.com) develops and manufactures allogeneic adult stem cells sold worldwide for research and clinical purposes. Stemedica is headquartered in San Diego, California.

For more information regarding this Media Release or Stemedica Cell Technologies, contact Dave McGuigan at dmcguigan (at) stemedica.com.

###

Read the full story at http://www.prweb.com/releases/stemedica-board/anthony-marlon/prweb3281184.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Prominent Cosmetic Dentist Dr. William Hoskyns Joins Leading Atlanta Practice
2. Prominent Farmington Plastic Surgeon Uses Two New Non-Surgical Procedures to Tighten Skin and Remove Fat
3. Prominent Chick Lit Novelist Laura Zigman Joins HealthCentrals MyBreastCancerNetwork.com as Expert
4. Prominent Orthopaedic Hand and Upper Extremity Surgeon Joins Radlink Board of Directors
5. Prominent Respiratory Therapist and Author Joins StopSmokingConnection.com as a COPD Expert
6. Prominent Health Care Executive, Kevin Kraushaar, Joins Triadvocates LLC as Managing Principal of DC Office
7. Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com
8. Highmark, Prominent Part of Pittsburgh City Skyline, to Go Dark for One Hour to Support the Environment
9. Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant
10. Prominent Advocate on HIV/AIDS Issues Joins Altarum Institute
11. ATS Medical Products Prominently Featured in International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) Scientific Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prominent Health Care Executive Joins Stemedica Board Of Directors
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm , ... corporate headquarters to a new, more expansive office space in order to accommodate ... purchased a distressed office building in Wethersfield, Conn. located at 936 Silas Deane ...
(Date:3/28/2017)... Petersburg Florida (PRWEB) , ... March 28, 2017 , ... ... Marine Corp to raise money to for the Toys for Tots Literacy Campaign at ... federal budget in excess of $70 billion, the U.S. ranks at number 14 internationally ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Thank you ... Diego on February 8-10. , This event was exclusive to providers and offered ... , The meeting took place at the Manchester Grand Hyatt where attendees gathered for ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... clear braces. People who want straight teeth without the extensive time commitment and ... Clearwater, FL, without acquiring a referral. A custom-designed series of virtually invisible aligners ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017 Therapix Biosciences ... company specializing in the development of cannabinoid-based drugs, today ... the United States of ... 40 ordinary shares of the Company, at a ... has granted the underwriters a 45-day over-allotment option ...
(Date:3/27/2017)... , March 27, 2017 LightIntegra Technology ... appointed William "Bill" Dubiel as President and Chief Executive ... elected to the Board of Directors of LightIntegra. ... Executive Chairman of LightIntegra. "This is ... President and Chief Executive Officer. We,ve selected a very ...
(Date:3/27/2017)... 27, 2017  A new survey from ... Medicare,s Competitive Bidding Program (CBP) significantly reduced beneficiary choice ... lack of choice forces beneficiaries to switch to unfamiliar ... consequences. AADE,s survey is the latest ... others pointing out the inherent problems with the CBP. ...
Breaking Medicine Technology: